Prognostic impact of δ-like ligand 4 and Notch1 in acute myeloid leukemia
Open Access
- 31 July 2012
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 28 (4) , 1503-1511
Abstract
Notch signaling plays a critical role in embryonic vascular development and tumor angiogenesis. The present study was conducted to investigate the prognostic role of the angiogenesis-related Notch ligand and the receptor in acute myeloid leukemia (AML) and assess whether their expression correlates with that of the vascular endothelial growth factor (VEGF) and angiopoietin (Ang)-2. Bone marrow mononuclear cells from 60 untreated AML patients and 40 healthy controls were obtained. Real-time RT-PCR was performed to evaluate the mRNA expression of delta-like ligand 4 (D114), Notchl, VEGF, VEGF receptor (VEGFR)-1, VEGFR-2, Ang-1, Ang-2 and Tie2. Western blot analysis was used to determine the protein levels of D114 and Notchl. The results demonstrated that D114, Notchl, VEGF, VEGFR-2 and Ang-2 expression were significantly higher in untreated AML patients than in the controls. Univariate analysis of factors associated with the overall survival showed a significantly shorter survival in patients with the unfavorable karyotype, higher D114 expression, higher Notchl expression, higher VEGF expression or higher Ang-2 expression. Furthermore, multivariate analysis revealed that the karyotype and expression levels of Notchl, D114, VEGF and Ang-2 were independent prognostic factors for overall survival. Additionally, the prognostic value of D114 expression (but not Notchl) was more significant in the subgroup consisting of patients with intermediate-risk cytogenetics. Subgroup analysis showed that Notchl and D114 expression levels had a prognostic impact on patients with high VEGF or Ang-2 levels. Taken together, our data provide evidence that the activation of the Notch pathway may indicate an unfavorable prognosis in AML. In particular, D114 may be a relevant prognostic marker in intermediate-risk AML.Keywords
This publication has 43 references indexed in Scilit:
- Angiogenesis: A Target in Solid Tumors, Also in Leukemia?Hematology-American Society Hematology Education Program, 2011
- Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel TherapiesJournal of Oncology, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasionCancer Letters, 2011
- Influence of the Tumor Microenvironment on AngiogenesisFuture Oncology, 2011
- Angiogenesis blockade as therapy for hepatocellular carcinoma: Progress and challengesJournal of Gastroenterology and Hepatology, 2010
- Contribution of bone microenvironment to leukemogenesis and leukemia progressionLeukemia, 2009
- Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survivalBlood, 2009
- The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemiaLeukemia, 2008
- Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemiaLeukemia Research, 2008